SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-121537
Filing Date
2017-04-12
Accepted
2017-04-12 17:26:56
Documents
6
Period of Report
2017-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d374895d8k.htm 8-K 19045
2 EX-1.1 d374895dex11.htm EX-1.1 224549
3 EX-5.1 d374895dex51.htm EX-5.1 46566
4 EX-99.1 d374895dex991.htm EX-99.1 6084
5 GRAPHIC g374895ex51logo.jpg GRAPHIC 4473
6 GRAPHIC g374895ex991logo.jpg GRAPHIC 22620
  Complete submission text file 0001193125-17-121537.txt   335203
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 17758661
SIC: 2834 Pharmaceutical Preparations